Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi

suck pdf from helios

10.1016/j.mehy.2020.109984

http://scihub22266oqcxt.onion/10.1016/j.mehy.2020.109984
suck pdf from google scholar
32554149!7286248!32554149
unlimited free pdf from europmc32554149    free
PDF from PMC    free
html from PMC    free
PDF vom PMID32554149  :  Publisher
PDF vom PMID32554149

suck abstract from ncbi

pmid32554149
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Aminoglycosides can be a better choice over macrolides in COVID-19 regimen: Plausible mechanism for repurposing strategy #MMPMID32554149
  • Chalichem NSS; Bethapudi B; Mundkinajeddu D
  • Med Hypotheses 2020[Jun]; 144 (ä): 109984 PMID32554149show ga
  • In the current COVID-19 pandemic, prioritizing the immunity enhancers is equally important to anti-virals. Defensins are the forgotten molecules that enhance the innate immunity against various microbes. Although macrolides like azithromycin and clarithromycin etc., have been reported to act against respiratory infections but they lack the ability of immunity enhancement through defensins. The aminoglycosides were proved to have defensin mediated antiviral activity, that could enhance the immunity. So, Consideration of aminoglycosides can be a double edge sword viz., against respiratory infection as well as Immunity enhancer (along with anti-virals) for COVID-19 regimen.
  • ä


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    109984 ä.144 2020